Mirum Pharmaceuticals
MIRM
MIRM
159 hedge funds and large institutions have $1.82B invested in Mirum Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 65 increasing their positions, 49 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% less ownership
Funds ownership: 114.23% → 113.23% (-1%)
7% less funds holding
Funds holding: 171 → 159 (-12)
31% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 36
Holders
159
Holding in Top 10
9
Calls
$3.64M
Puts
$2.44M
Top Buyers
| 1 | +$76M | |
| 2 | +$26.9M | |
| 3 | +$17.4M | |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$16.8M |
| 5 |
ClearBridge Investments
New York
|
+$14.9M |
Top Sellers
| 1 | -$45.3M | |
| 2 | -$36.2M | |
| 3 | -$14.1M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$13.6M |
| 5 |
Millennium Management
New York
|
-$9.38M |